Paratek Pharma

Paratek Pharmaceuticals (NASDAQ: PRTK) is a biopharmaceutical company that develops transformative solutions for patients, both in and out of the hospital, with diseases that are not responsive to current treatments. We focus on drugs that target infectious disease and other difficult to treat conditions. Today, we have a particularly promising antibiotic called Omadacycline for serious community acquired infections where resistance is of concern.